tiprankstipranks
SELLAS Life Sciences Group (SLS)
NASDAQ:SLS
US Market

SELLAS Life Sciences Group (SLS) Financial Statements

Compare
969 Followers

SELLAS Life Sciences Group Financial Overview

SELLAS Life Sciences Group's market cap is currently $99.02M. The company's EPS TTM is $-0.538; its P/E ratio is ―; SELLAS Life Sciences Group is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.00M$ 7.60M$ 1.90M
Gross Profit$ 0.00$ 0.00$ 900.00K$ 7.40M$ 1.90M
Operating Income$ -31.51M$ -37.87M$ -41.95M$ -25.29M$ -16.98M
EBITDA$ -31.51M$ 529.00K$ -31.95M$ -19.66M$ -16.40M
Net Income$ -30.88M$ -37.34M$ -40.65M$ -20.70M$ -16.76M
Balance Sheet
Cash & Short-Term Investments$ 13.99M$ 2.53M$ 17.13M$ 21.36M$ 35.30M
Total Assets$ 19.43M$ 6.22M$ 20.94M$ 26.27M$ 46.05M
Total Debt$ 1.00M$ 906.00K$ 945.00K$ 808.00K$ 991.00K
Net Debt$ -12.98M$ -1.62M$ -16.18M$ -20.55M$ -34.31M
Total Liabilities$ 9.97M$ 14.20M$ 16.09M$ 5.93M$ 18.09M
Stockholders' Equity$ 9.46M$ -7.98M$ 4.85M$ 20.35M$ 27.96M
Cash Flow
Free Cash Flow$ -35.40M$ -36.91M$ -28.31M$ -26.02M$ -10.42M
Operating Cash Flow$ -35.40M$ -31.41M$ -23.81M$ -26.02M$ -10.42M
Investing Cash Flow$ 0.00$ -5.50M$ -4.50M$ 0.00$ 0.00
Financing Cash Flow$ 46.76M$ 22.32M$ 24.08M$ 12.07M$ 38.44M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

SELLAS Life Sciences Group Debt to Assets

SELLAS Life Sciences Group Cash Flow

SELLAS Life Sciences Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis